AEE-788

TypeName: Business Offer
Category:
Offer Date:2019/09/04
Country: United States
Summary: AEE-788 is an orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. https://www.bocsci.com/aee-788-cas-497839-62-0-item-258485.html
Description:
OfferId: 5459
Name:Alex Brown
Telphone:
Categories
No Man flag